MA37523A1 - St2 antigen binding protein - Google Patents

St2 antigen binding protein

Info

Publication number
MA37523A1
MA37523A1 MA37523A MA37523A MA37523A1 MA 37523 A1 MA37523 A1 MA 37523A1 MA 37523 A MA37523 A MA 37523A MA 37523 A MA37523 A MA 37523A MA 37523 A1 MA37523 A1 MA 37523A1
Authority
MA
Morocco
Prior art keywords
antibodies
methods
antigen binding
binding protein
antigen
Prior art date
Application number
MA37523A
Other languages
French (fr)
Other versions
MA37523B1 (en
Inventor
Dirk E Smith
Ian Foltz
Chadwick T King
Ai Ching Lim
Rutilio Clark
Michael R Comeau
Randal R Ketchem
Donghui Shi
Xiaoshan Min
Zhulun Wang
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Priority claimed from PCT/US2013/041656 external-priority patent/WO2013173761A2/en
Publication of MA37523A1 publication Critical patent/MA37523A1/en
Publication of MA37523B1 publication Critical patent/MA37523B1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La présente invention concerne des compositions et des procédés se rapportant à des protéines de liaison aux antigènes qui se lient à l'antigène st2 humain, comprenant des anticorps. Dans des modes de réalisation particuliers, l'invention pourvoit à des anticorps anti-st2 complètement humains et à des dérivés et des variants associés. L'invention concerne en outre des acides nucléiques codant pour de tels anticorps, fragments d'anticorps, variants et dérivés. L'invention concerne également des procédés de fabrication et des méthodes d'utilisation de tels anticorps, notamment des méthodes de traitement et de prévention de troubles auto-immuns et inflammatoires.The present invention provides compositions and methods relating to antigen-binding proteins that bind to human st2 antigen, including antibodies. In particular embodiments, the invention provides completely human anti-st2 antibodies and derivatives and associated variants. The invention further relates to nucleic acids encoding such antibodies, antibody fragments, variants and derivatives. The invention also relates to methods of making and methods of using such antibodies, including methods of treating and preventing autoimmune and inflammatory disorders.

MA37523A 2012-05-18 2013-05-17 St2 antigen binding protein MA37523B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261649147P 2012-05-18 2012-05-18
PCT/US2013/041656 WO2013173761A2 (en) 2012-05-18 2013-05-17 St2 antigen binding proteins

Publications (2)

Publication Number Publication Date
MA37523A1 true MA37523A1 (en) 2017-09-29
MA37523B1 MA37523B1 (en) 2018-06-29

Family

ID=58050102

Family Applications (1)

Application Number Title Priority Date Filing Date
MA37523A MA37523B1 (en) 2012-05-18 2013-05-17 St2 antigen binding protein

Country Status (3)

Country Link
AR (1) AR118080A2 (en)
MA (1) MA37523B1 (en)
UA (1) UA113308C2 (en)

Also Published As

Publication number Publication date
MA37523B1 (en) 2018-06-29
UA113308C2 (en) 2017-01-10
AR118080A2 (en) 2021-09-15

Similar Documents

Publication Publication Date Title
MA33757B1 (en) HUMAN IL-23 ANTIGEN BINDING PROTEINS
MA35345B1 (en) Proteins of antigen binding with increased binding to fcrn
MA49599A1 (en) Antibodies specific to cd47 and pd-l1
MA42530B1 (en) Constructions of Bispecific Antibodies Binding to dll3 and cd3
MA40801A1 (en) Anti-cd3 antibody, anti-cd123 antibody and bispecific antibodies binding specifically to cd3 and / or cd123
MA42542B1 (en) Molecules Binding to pd-1 and Corresponding Methods of Use
MA33402B1 (en) COMPOSITIONS AND METHODS FOR TARGETING COMPLEMENT C3B PROTEIN BY ANTIBODIES
MA30353B1 (en) ANTIBODIES BINDING HUMAN BETA TYROSINE PHOSPHATASE PROTEIN (HPTPBETA) AND USES THEREOF.
MA35174B1 (en) CD3 binding molecules able to bind to human and non-human cd3
PH12016501691A1 (en) Antibodies to matrix metalloproteinase 9
MA40041B1 (en) Anti-gitr antibodies and methods of use thereof
MA33387B1 (en) POLYPEPTIDES AND PROCESSING METHOD
WO2008121615A3 (en) Antibody formulation
UA109633C2 (en) HUMAN ANTIBODY AGAINST TISSUE FACTOR
MA33213B1 (en) ANTAGONIST ANTIBODY SPECIFIC TO A HETERODIMERE ALPHA-4-BETA-7
MA35428B1 (en) Proteins and peptides podified
BRPI0716438A8 (en) Interleukin-1,3 binding proteins
EP3255063A3 (en) Antibodies to matrix metalloproteinase 9
UA108066C2 (en) PROTEINS RELATING TO HUMAN CGRP RECEPTORS
MA39061A1 (en) Aplnr modulators and their uses
MA32928B1 (en) ANTI-CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER
MA34927B1 (en) ANTI-ACE ANTIBODIES
TW200801041A (en) Antibodies against human IL-22 and uses therefor
MA29279B1 (en) ANTIGEN BINDING MOLECULES BINDING TO THE EGFR RECEPTOR, VECTORS ENCODING THESE MOLECULES AND THEIR APPLICATIONS
EA201290589A1 (en) CD127-BINDING PROTEINS